Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows

About one-fourth of adults globally suffer from nonalcoholic fatty liver disease (NAFLD), which is becoming a leading cause of chronic liver disease worldwide. Its prevalence has rapidly increased in recent years, and is projected to increase even more. NAFLD is a leading cause of hepatocellular car...

Descripción completa

Detalles Bibliográficos
Autores principales: Costante, Federico, Airola, Carlo, Santopaolo, Francesco, Gasbarrini, Antonio, Pompili, Maurizio, Ponziani, Francesca Romana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516656/
https://www.ncbi.nlm.nih.gov/pubmed/36187401
http://dx.doi.org/10.4251/wjgo.v14.i9.1622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516656/
https://www.ncbi.nlm.nih.gov/pubmed/36187401
http://dx.doi.org/10.4251/wjgo.v14.i9.1622

Ejemplares similares